MedPath
FDA Product

DUAKLIR PRESSAIR

Product approved by U.S. Food and Drug Administration (US)

Basic Information

DUAKLIR PRESSAIR

70515-001

Regulatory Information

70515-001

NDA210595

C73594

August 1, 2022

USA

These highlights do not include all the information needed to use DUAKLIR PRESSAIR safely and effectively. See full prescribing information for DUAKLIR PRESSAIR.DUAKLIR PRESSAIR (aclidinium bromide and formoterol fumarate) inhalation powder, for oral inhalationInitial U.S. Approval: 2019

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

118094829

Active Ingredients

ACLIDINIUM BROMIDE

Quantity: 400 ug in 1 1

Code: UQW7UF9N91

Class Code: ACTIB

FORMOTEROL FUMARATE

Quantity: 12 ug in 1 1

Code: W34SHF8J2K

Class Code: ACTIB

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

Active Moieties

ACLIDINIUM

Code: K17VY42F6C

FORMOTEROL

Code: 5ZZ84GCW8B

© Copyright 2025. All Rights Reserved by MedPath